Market Cap: $6.81M
Market Cap: $6.81M
Exicure Expands Therapeutic Horizons with Strategic Acquisition of GPCR Therapeutics Exicure, Inc. announces a pivotal acquisition that positions the company for significant advancements in cancer tre…
Exicure Expands Its Therapeutic Portfolio with Strategic Acquisition of GPCR Therapeutics Exicure, Inc. has recently solidified its commitment to advancing innovative cancer therapies through the acqu…
Exicure Expands Its Research Horizons with GPCR Therapeutics Acquisition Exicure, Inc. has signed a Memorandum of Understanding (MOU) with GPCR Therapeutics, Inc., marking a significant step in the co…
Exicure Expands Drug Development Capabilities Through Acquisition of GPCR USA Exicure, Inc. has solidified its position in the biotech landscape by signing a Memorandum of Understanding (MOU) with GPC…
Exicure’s Strategic Shift: Embracing New Leadership and Funding Opportunities Exicure, Inc. recently embarks on a transformative journey following a significant equity financing deal with HiTron Syste…
Exicure Strengthens Its Position with Strategic Investment and Corporate Restructuring Exicure, Inc., a biotechnology company specializing in nucleic acid therapies, is poised for a significant transf…